Evidence map›Paper›PMID 42503476›Full record

ArticleChemPlusChem2026

The Role of Cyclic Diketopiperazine in the Formation of Polypeptides on Silica Surfaces.

Ola El Samrout, Rita Arnesi, Samuele Mistrali, Chiara Nannuzzi, Gloria Berlier

Abstract read
In one paragraph

Article in ChemPlusChem, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ola El SamroutDepartment of Chemistry, NIS and INSTM Centers, University of Turin, Torino, Italy.ORCID https://orcid.org/0000-0001-6316-5468
Rita ArnesiDepartment of Chemistry, NIS and INSTM Centers, University of Turin, Torino, Italy.
Samuele MistraliDepartment of Chemistry, NIS and INSTM Centers, University of Turin, Torino, Italy.
Chiara NannuzziDepartment of Chemistry, NIS and INSTM Centers, University of Turin, Torino, Italy.ORCID https://orcid.org/0000-0003-2848-6201
Gloria BerlierDepartment of Chemistry, NIS and INSTM Centers, University of Turin, Torino, Italy.ORCID https://orcid.org/0000-0001-7720-3584

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diketopiperazine (DKP), a recurring product of silica-catalyzed amino acid polymerization, is a molecule of interest in the origin of life studies, as well in the industrial medicinal chemistry. Its role in the peptide bond formation reactions is controversial as it is considered sometimes as a stable, dead-end product for the oligomerization reaction. We tried to elucidate the parameters that govern the DKP opening on silica surfaces of low and high surface areas in the frame of glycine polymerization reaction, when DKP is adsorbed from gas and liquid phases, or subjected to temperature and humidity fluctuations cycles. The formed products were characterized by infrared spectroscopy, thermogravimetric analysis, and X-ray diffraction. The results reveal that DKP represents an efficient intermediate for the polymerization reaction leading to the formation of linear peptides on silica surfaces. Abundant oligomers with β-sheet secondary structures are formed depending on the DKP loading and the silica surface. The crucial role of the silica surface including the "nearly free" silanols in the adsorption, opening, and reaction of DKP to form linear chains was shown. These conclusions highlight the complexity of the DKP surface chemistry in the polymerization reaction and can improve the understanding when dealing with geochemical prebiotic scenarios.

Indexed as

cyclic dimerglycinelinear peptidespolymerizationsilica

Identifiers

PMID42503476
PMCPMC13402219

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.